pargyline has been researched along with Disorders of Sex Development in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Disorders of Sex Development: In gonochoristic organisms, congenital conditions in which development of chromosomal, gonadal, or anatomical sex is atypical. Effects from exposure to abnormal levels of GONADAL HORMONES in the maternal environment, or disruption of the function of those hormones by ENDOCRINE DISRUPTORS are included.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dörner, G | 1 |
1 review available for pargyline and Disorders of Sex Development
| Article | Year |
|---|---|
Sex hormones and neurotransmitters as mediators for sexual differentiation of the brain.
Topics: Acetylcholinesterase; Androgens; Animals; Avoidance Learning; Brain; Castration; Disorders of Sex De | 1981 |